Last 12 months
Inside the activity.
13 purchase rows · 7 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 4 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 3 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 5 | 3 |
| Jun 2026 | 1 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 2 |
| Sep 2026 | 0 | 2 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| November 20, 2025 Filed Nov 24, 2025 21:04 UTC |
KIRK THOMAS FDirector
|
PurchaseCommon Stock | 4,902 | $0.72 | $3,529.44 |
DisclosureSEC source: 0001193125-25-293665 · ownership.xml · nonDerivative · entry 1 KIRK THOMAS F · CIK 0001258258 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 479,322 F1 · shares: Represents open market purchases. F2 · price: Shares were purchased in multiple lots, each executing at $0.72 per share. Reporting Party agrees to provide details of the transactions to the SEC upon request. Read SEC document |
| November 19, 2025 Filed Nov 22, 2025 00:22 UTC |
Crowley Thomas Aloysius Jr.Director
|
PurchaseCommon Stock | 385 | $0.77 | $294.53 |
DisclosureSEC source: 0001193125-25-291710 · ownership.xml · nonDerivative · entry 2 Crowley Thomas Aloysius Jr. · CIK 0001706753 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · By immediate family memeber of reporting person Disclosed balance after: 479 F2 · price: Represents weighted average purchase price F3 · balance_after: Represents shares held by the Reporting Person's immediate family member. The Reporting Person disclaims beneficial ownership of such shares for purposes of Section 16 except to the extent of his pecuniary interest therein, if any, and this report shall not be deemed an admission that such shares are beneficially owned by him for Section 16 or any other purpose. Read SEC document |
| November 18, 2025 Filed Nov 22, 2025 00:22 UTC |
Crowley Thomas Aloysius Jr.Director
|
PurchaseCommon Stock | 4,000 | $0.73 | $2,938.00 |
DisclosureSEC source: 0001193125-25-291710 · ownership.xml · nonDerivative · entry 1 Crowley Thomas Aloysius Jr. · CIK 0001706753 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 75,748 F1 · shares: Represents an open market purchase in a single transaction. Read SEC document |
| September 09, 2025 Filed Sep 11, 2025 20:11 UTC |
GUDONIS PAUL RDirector · Chief Executive Officer
|
GiftCommon Stock | 10,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001015994-25-000004 · ownership.xml · nonDerivative · entry 1 GUDONIS PAUL R · CIK 0001015994 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,249,013 F1 · shares: Represents a gift of 10,000 shares by the Reporting Party to a third party. This represents a bona fide gift where the Reporting Party is not receiving any direct or indirect benefit. Read SEC document |
| August 25, 2025 Filed Aug 26, 2025 12:10 UTC |
KIRK THOMAS FDirector
|
PurchaseCommon Stock | 50,000 | $1.15 | $57,500.00 |
DisclosureSEC source: 0001258258-25-000004 · ownership.xml · nonDerivative · entry 1 KIRK THOMAS F · CIK 0001258258 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 474,420 F1 · shares: Represents open market purchases. F2 · price: Shares were purchased in multiple lots, each executing at $1.15 per share. Reporting Party agrees to provide details of the transactions to the SEC upon request. Read SEC document |
| August 18, 2025 Filed Aug 19, 2025 11:23 UTC |
KIRK THOMAS FDirector
|
PurchaseCommon Stock | 50,000 | $1.10 | $55,000.00 |
DisclosureSEC source: 0000950170-25-109938 · ownership.xml · nonDerivative · entry 1 KIRK THOMAS F · CIK 0001258258 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 424,420 F1 · shares: Represents open market purchases. F2 · price: Shares were purchased in two transactions, each executing at $1.10 per share. Reporting Party agrees to provide details of the transactions to the SEC upon request. Read SEC document |
| August 15, 2025 Filed Aug 18, 2025 11:51 UTC |
GUDONIS PAUL RDirector · Chief Executive Officer
|
PurchaseCommon Stock | 50,000 | $0.95 | $47,295.00 |
DisclosureSEC source: 0000950170-25-109565 · ownership.xml · nonDerivative · entry 1 GUDONIS PAUL R · CIK 0001015994 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,259,013 F1 · shares: Represents open market purchases. F2 · price: Represents volume weighted average purchase price. Shares purchased in multiple lots at purchase prices ranging from $0.9289 to $0.9687 per share. Reporting Party agrees to provide details of these transactions to the SEC upon request. Read SEC document |
| June 30, 2025 Filed Jul 2, 2025 12:20 UTC |
Kovelman HarryChief Medical Officer
|
Tax withholdingCommon Stock | 13,054 | $2.19 | $28,588.26 |
DisclosureSEC source: 0000950170-25-092544 · ownership.xml · nonDerivative · entry 1 Kovelman Harry · CIK 0001853204 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 140,618 F1 · shares: Represents sale of shares on June 30, 2025, solely to cover income taxes on the vesting of restricted stock units on June 28, 2025, pursuant to an irrevocable election made by the Reporting Party on May 12, 2025. Read SEC document |
| June 30, 2025 Filed Jul 2, 2025 12:16 UTC |
HENRY DAVID AChief Financial Officer
|
Tax withholdingCommon Stock | 23,587 | $2.19 | $51,655.53 |
DisclosureSEC source: 0000950170-25-092541 · ownership.xml · nonDerivative · entry 1 HENRY DAVID A · CIK 0001195842 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 427,900 F1 · shares: Represents sale of shares on June 30, 2025 solely to cover income taxes on the vesting of restricted stock units on June 28, 2025, pursuant to an irrevocable election made by the Reporting Party on May 9, 2025. Read SEC document |
| June 11, 2025 Filed Jun 12, 2025 23:34 UTC |
Getz Heather CDirector
|
GrantCommon Stock | 29,720 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-25-085722 · ownership.xml · nonDerivative · entry 1 Getz Heather C · CIK 0001481485 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 41,754 F1 · shares: Represents grant of Restricted Stock Units ("RSU's") under the Issuer's 2018 Stock Option and Incentive Plan. These RSU's shall vest in four equal quarterly installments beginning on September 11, 2025. Read SEC document |
| June 11, 2025 Filed Jun 12, 2025 23:40 UTC |
Morris Milton MayoDirector
|
GrantCommon Stock | 29,720 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-25-085725 · ownership.xml · nonDerivative · entry 1 Morris Milton Mayo · CIK 0001454309 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 144,687 F1 · shares: Represents grant of Restricted Stock Units ("RSU's") under the Issuer's 2018 Stock Option and Incentive Plan. These RSU's shall vest in four equal quarterly installments beginning on September 11, 2025. Read SEC document |
| June 11, 2025 Filed Jun 12, 2025 23:52 UTC |
KIRK THOMAS FDirector
|
GrantCommon Stock | 29,720 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-25-085735 · ownership.xml · nonDerivative · entry 1 KIRK THOMAS F · CIK 0001258258 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 374,420 F1 · shares: Represents grant of Restricted Stock Units ("RSU's") under the Issuer's 2018 Stock Option and Incentive Plan. These RSU's shall vest in four equal quarterly installments beginning on September 11, 2025. Read SEC document |
| June 11, 2025 Filed Jun 12, 2025 23:47 UTC |
Crowley Thomas Aloysius Jr.Director
|
GrantCommon Stock | 29,720 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-25-085731 · ownership.xml · nonDerivative · entry 1 Crowley Thomas Aloysius Jr. · CIK 0001706753 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 71,748 F1 · shares: Represents grant of Restricted Stock Units ("RSU's") under the Issuer's 2018 Stock Option and Incentive Plan. These RSU's shall vest in four equal quarterly installments beginning on September 11, 2025. Read SEC document |
| June 11, 2025 Filed Jun 13, 2025 20:51 UTC |
GUDONIS PAUL RDirector · Chief Executive Officer
|
GrantCommon Stock | 157,342 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-25-086332 · ownership.xml · nonDerivative · entry 1 GUDONIS PAUL R · CIK 0001015994 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,209,013 F1 · shares: Represents grant of Restricted Stock Units ("RSU's") under the Issuer's 2018 Stock Option and Incentive Plan. These RSU's shall vest in three equal annual installments beginning on June 11, 2026. Read SEC document |
| June 11, 2025 Filed Jun 13, 2025 21:14 UTC |
Kovelman HarryChief Medical Officer
|
GrantCommon Stock | 62,938 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-25-086369 · ownership.xml · nonDerivative · entry 1 Kovelman Harry · CIK 0001853204 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 153,672 F1 · shares: Represents grant of Restricted Stock Units ("RSU's") under the Issuer's 2018 Stock Option and Incentive Plan. These RSU's shall vest in three equal annual installments beginning on June 11, 2026. Read SEC document |
| June 11, 2025 Filed Jun 13, 2025 21:08 UTC |
Mitchell MicahChief Commercial Officer
|
GrantCommon Stock | 59,440 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-25-086357 · ownership.xml · nonDerivative · entry 1 Mitchell Micah · CIK 0001746072 · Chief Commercial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 199,709 F1 · shares: Represents grant of Restricted Stock Units ("RSU's") under the Issuer's 2018 Stock Option and Incentive Plan. These RSU's shall vest in three equal annual installments beginning on June 11, 2026. Read SEC document |
| June 11, 2025 Filed Jun 13, 2025 20:56 UTC |
HENRY DAVID AChief Financial Officer
|
GrantCommon Stock | 76,398 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-25-086340 · ownership.xml · nonDerivative · entry 1 HENRY DAVID A · CIK 0001195842 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 451,487 F1 · shares: Represents grant of Restricted Stock Units ("RSU's") under the Issuer's 2018 Stock Option and Incentive Plan. These RSU's shall vest in three equal annual installments beginning on June 11, 2026. Read SEC document |
| June 06, 2025 Filed Jun 6, 2025 23:46 UTC |
Kovelman HarryChief Medical Officer
|
Tax withholdingCommon Stock | 5,743 | $2.97 | $17,056.71 |
DisclosureSEC source: 0000950170-25-083376 · ownership.xml · nonDerivative · entry 1 Kovelman Harry · CIK 0001853204 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 90,734 F1 · shares: Represents sale of shares on June 6, 2025 solely to cover income taxes on the vesting of restricted stock units ("RSU's") on June 5, 2025 under the Issuer's 2018 Stock Option and Incentive Plan, pursuant to an irrevocable election made by the Reporting Party on May 12, 2025. Read SEC document |
| June 06, 2025 Filed Jun 6, 2025 23:26 UTC |
HENRY DAVID AChief Financial Officer
|
Tax withholdingCommon Stock | 8,373 | $2.97 | $24,867.81 |
DisclosureSEC source: 0000950170-25-083362 · ownership.xml · nonDerivative · entry 1 HENRY DAVID A · CIK 0001195842 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 375,089 F1 · shares: Represents sale of shares on June 6, 2025 solely to cover income taxes on the vesting of restricted stock units ("RSU's) on June 5, 2025 under the Issuer's 2018 Stock Option and Incentive Plan, pursuant an irrevocable election made by the Reporting Party on May 9, 2025. Read SEC document |
| May 15, 2025 Filed May 15, 2025 20:36 UTC |
GUDONIS PAUL RDirector · Chief Executive Officer
|
PurchaseCommon Stock | 30,000 | $3.22 | $96,612.00 |
DisclosureSEC source: 0000950170-25-072776 · ownership.xml · nonDerivative · entry 1 GUDONIS PAUL R · CIK 0001015994 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,051,671 F1 · shares: Represents open market purchases in multiple lots at prices ranging from $3.15 to $3.295 per share. Reporting party agrees to provide details of the trades to the SEC upon request. Read SEC document |
| May 15, 2025 Filed May 15, 2025 20:53 UTC |
KIRK THOMAS FDirector
|
PurchaseCommon Stock | 36,824 | $3.25 | $119,678.00 |
DisclosureSEC source: 0000950170-25-072803 · ownership.xml · nonDerivative · entry 2 KIRK THOMAS F · CIK 0001258258 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 344,700 F1 · shares: Shares purchased in multiple lots in open market transactions on May 14-15, 2025. Purchase price of each lot was $3.25. Reporting Party agrees to provide details of the transactions to the SEC upon request. Read SEC document |
| May 14, 2025 Filed May 15, 2025 20:53 UTC |
KIRK THOMAS FDirector
|
PurchaseCommon Stock | 1,943 | $3.25 | $6,314.75 |
DisclosureSEC source: 0000950170-25-072803 · ownership.xml · nonDerivative · entry 1 KIRK THOMAS F · CIK 0001258258 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 307,876 F1 · shares: Shares purchased in multiple lots in open market transactions on May 14-15, 2025. Purchase price of each lot was $3.25. Reporting Party agrees to provide details of the transactions to the SEC upon request. Read SEC document |
| May 14, 2025 Filed May 15, 2026 22:00 UTC |
Mitchell MicahChief Commercial Officer
|
SaleCommon Stock | 90,231 | $0.86 | $77,688.89 |
DisclosureSEC source: 0001193125-26-227325 · ownership.xml · nonDerivative · entry 1 Mitchell Micah · CIK 0001746072 · Chief Commercial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 109,478 F1 · shares: Represents sale of common stock on May 14, 2026 in a series of open market transactions. F2 · price: Represents weighted average sales price. Shares were sold in multiple lots at prices ranging from $0.85 to $0.889 per share. Reporting party agrees to provide details of the transactions to the SEC upon request. Read SEC document |
| May 12, 2025 Filed May 14, 2025 12:27 UTC |
KIRK THOMAS FDirector
|
PurchaseCommon Stock | 50,000 | $3.35 | $167,500.00 |
DisclosureSEC source: 0000950170-25-070945 · ownership.xml · nonDerivative · entry 1 KIRK THOMAS F · CIK 0001258258 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 305,933 F1 · shares: Shares purchased in multiple lots in open market transactions on May 12, 2025. Purchase price of each lot was $3.35. Reporting Party agrees to provide details of the transactions to the SEC upon request. Read SEC document |
| March 14, 2025 Filed Mar 14, 2025 21:45 UTC Amendment |
Mitchell MicahChief Commercial Officer
|
SaleCommon Stock | 48,000 | $5.16 | $247,564.80 |
DisclosureSEC source: 0000950170-25-039617 · ownership.xml · nonDerivative · entry 1 Mitchell Micah · CIK 0001746072 · Chief Commercial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 140,572 F1 · shares: Sales were made on March 14, 2025 in open market transactions. F2 · price: Represents average selling price. Sales were made in multiple lots at prices ranging from $5.055 to $5.25 per share. The Reporting Party agrees to provide the SEC with details regarding these transactions upon request. Read SEC document |
| March 14, 2025 Filed Mar 14, 2025 21:36 UTC |
Mitchell MicahChief Commercial Officer
|
SaleCommon Stock | 48,000 | $5.16 | $247,564.80 |
DisclosureSEC source: 0000950170-25-039607 · ownership.xml · nonDerivative · entry 1 Mitchell Micah · CIK 0001746072 · Chief Commercial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 140,572 F1 · shares: Sales were made on March 14, 2025 in open market transactions. F2 · price: Represents average selling price. Sales were made in multiple lots at prices ranging from $5.055 to $5.25 per share. The Reporting Party agrees to provide the SEC with details regarding these transactions upon request. Read SEC document |
| March 14, 2025 Filed Mar 21, 2025 20:15 UTC Amendment |
Mitchell MicahChief Commercial Officer
|
SaleCommon Stock | 48,000 | $5.16 | $247,564.80 |
DisclosureSEC source: 0000950170-25-043214 · ownership.xml · nonDerivative · entry 1 Mitchell Micah · CIK 0001746072 · Chief Commercial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 140,269 F1 · shares: Sales were made on March 14, 2025 in open market transactions. F2 · price: Represents average selling price. Sales were made in multiple lots at prices ranging from $5.055 to $5.25 per share. The Reporting Party agrees to provide the SEC with details regarding these transactions upon request. Read SEC document |
| March 13, 2025 Filed Mar 13, 2025 20:41 UTC |
Kovelman HarryChief Medical Officer
|
Tax withholdingCommon Stock | 1,496 | $5.22 | $7,809.12 |
DisclosureSEC source: 0000950170-25-038823 · ownership.xml · nonDerivative · entry 3 Kovelman Harry · CIK 0001853204 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 96,477 F4 · shares: Shares sold on March 13, 2025 solely to cover income taxes on a vesting of restricted stock units on March 11, 2025, pursuant to an irrevocable election made by the Reporting Party on March 11, 2025. Read SEC document |
| March 13, 2025 Filed Mar 13, 2025 20:33 UTC |
Mitchell MicahChief Commercial Officer
|
Tax withholdingCommon Stock | 1,283 | $5.22 | $6,697.26 |
DisclosureSEC source: 0000950170-25-038808 · ownership.xml · nonDerivative · entry 2 Mitchell Micah · CIK 0001746072 · Chief Commercial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 188,572 F2 · shares: Represents sale of shares solely to cover income taxes due on the vesting of restricted stock units on March 11, 2025, pursuant to an irrevocable election by the Reporting Party on March 11, 2025 Read SEC document |
| March 13, 2025 Filed Mar 13, 2025 20:35 UTC |
HENRY DAVID AChief Financial Officer
|
Tax withholdingCommon Stock | 2,019 | $5.22 | $10,539.18 |
DisclosureSEC source: 0000950170-25-038812 · ownership.xml · nonDerivative · entry 2 HENRY DAVID A · CIK 0001195842 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 383,462 F2 · shares: Represents the sale of shares March 13, 2025 solely to cover income taxes due on the vesting of RSU's on March 11, 2025, pursuant to an irrevocable election made by the Reporting Party on March 11, 2025. Read SEC document |
| March 13, 2025 Filed Mar 14, 2025 21:18 UTC Amendment |
Mitchell MicahChief Commercial Officer
|
Tax withholdingCommon Stock | 1,283 | $5.22 | $6,697.26 |
DisclosureSEC source: 0000950170-25-039582 · ownership.xml · nonDerivative · entry 2 Mitchell Micah · CIK 0001746072 · Chief Commercial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 188,572 F2 · shares: Represents sale of shares solely to cover income taxes due on the vesting of restricted stock units on March 11, 2025, pursuant to an irrevocable election by the Reporting Party on March 11, 2025 Read SEC document |
| March 13, 2025 Filed Mar 15, 2025 01:00 UTC |
KIRK THOMAS FDirector
|
PurchaseCommon Stock | 7,400 | $5.00 | $37,000.00 |
DisclosureSEC source: 0000950170-25-039751 · ownership.xml · nonDerivative · entry 1 KIRK THOMAS F · CIK 0001258258 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 255,933 F1 · shares: Shares purchased in a single lot in an open market transaction on March 13, 2025. Read SEC document |
| March 12, 2025 Filed Mar 13, 2025 20:41 UTC |
Kovelman HarryChief Medical Officer
|
SaleCommon Stock | 30,000 | $5.50 | $165,018.00 |
DisclosureSEC source: 0000950170-25-038823 · ownership.xml · nonDerivative · entry 2 Kovelman Harry · CIK 0001853204 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 97,973 F2 · shares: Represents sale of shares in an open market transaction F3 · price: Represents average sales price. Transactions were completed in multiple lots at prices ranging from $5.50 to $5.53 per share. Reporting Party agrees to provide details of the trades to the SEC upon request. Read SEC document |
| March 11, 2025 Filed Mar 13, 2025 20:37 UTC |
GUDONIS PAUL RDirector · Chief Executive Officer
|
GrantCommon Stock | 6,708 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-25-038813 · ownership.xml · nonDerivative · entry 1 GUDONIS PAUL R · CIK 0001015994 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,021,671 F1 · shares: Represents a grant of restricted stock units ("RSU's) on March 11, 2025 under the Issuer's 2018 Stock Option and Incentive Plan. The RSU's immediately vested on the grant date. Read SEC document |
| March 11, 2025 Filed Mar 13, 2025 20:41 UTC |
Kovelman HarryChief Medical Officer
|
GrantCommon Stock | 3,553 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-25-038823 · ownership.xml · nonDerivative · entry 1 Kovelman Harry · CIK 0001853204 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 127,973 F1 · shares: Represents grant of restricted stock units ("RSU's") on March 11, 2025 under the Issuer's 2018 Stock Option and Incentive Plan. The RSU's became fully vested on the grant date. Read SEC document |
| March 11, 2025 Filed Mar 13, 2025 20:35 UTC |
HENRY DAVID AChief Financial Officer
|
GrantCommon Stock | 4,106 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-25-038812 · ownership.xml · nonDerivative · entry 1 HENRY DAVID A · CIK 0001195842 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 385,481 F1 · shares: Represents grant of restricted stock units ("RSU's) on March 11, 2025 under the Issuer's 2018 Stock Option and Incentive Plan. The RSU's fully vested on the grant date Read SEC document |
| March 11, 2025 Filed Mar 14, 2025 21:18 UTC Amendment |
Mitchell MicahChief Commercial Officer
|
GrantCommon Stock | 3,737 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-25-039582 · ownership.xml · nonDerivative · entry 1 Mitchell Micah · CIK 0001746072 · Chief Commercial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 189,855 F1 · shares: Represents a grant of restricted stock units ("RSU's) on March 11, 2025 under the Issuer's 2018 Stock Option and Incentive Plan. The RSU's immediately vested on the grant date. Read SEC document |
| February 13, 2025 Filed Feb 18, 2025 21:33 UTC |
GUDONIS PAUL RDirector · Chief Executive Officer
|
Exercise / conversionStock Option · Derivative | 694 | $0.00 Strike: $0.05 | $0.00 |
DisclosureSEC source: 0000950170-25-022351 · ownership.xml · derivative · entry 2 GUDONIS PAUL R · CIK 0001015994 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 694 shares Expires 2025-03-17 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 13, 2025 Filed Feb 18, 2025 21:33 UTC |
GUDONIS PAUL RDirector · Chief Executive Officer
|
Exercise / conversionCommon Stock | 694 | $0.05 | $33.31 |
DisclosureSEC source: 0000950170-25-022351 · ownership.xml · nonDerivative · entry 1 GUDONIS PAUL R · CIK 0001015994 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,014,963 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Represents exercise of stock options granted on March 18, 2015 under the Company's Stock Option and Incentive Plan at an exercise price of $0.048 per share. Read SEC document |
| November 04, 2024 Filed Nov 5, 2024 21:36 UTC |
Kovelman HarryChief Medical Officer
|
Tax withholdingCommon Stock | 121 | $3.70 | $447.70 |
DisclosureSEC source: 0000950170-24-121547 · ownership.xml · nonDerivative · entry 1 Kovelman Harry · CIK 0001853204 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 123,314 F1 · shares: Represents sale of shares on November 4, 2024 solely to cover income taxes due on the vesting of restricted stock units on November 2, 2024, pursuant to an irrevocable election made by the Reporting Porty in conjunction with the original grant in November 2020. Read SEC document |
| October 03, 2024 Filed Oct 4, 2024 20:20 UTC |
Kovelman HarryChief Medical Officer
|
Tax withholdingCommon Stock | 121 | $3.86 | $467.06 |
DisclosureSEC source: 0000950170-24-112915 · ownership.xml · nonDerivative · entry 1 Kovelman Harry · CIK 0001853204 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 123,435 F1 · shares: Represents sale of shares solely to cover income taxes due on the vesting of restricted stock units on October 2, 2024, pursuant to an irrevocable election made by the Reporting Porty in conjunction with the original grant in November 2020. Read SEC document |
| September 05, 2024 Filed Sep 9, 2024 20:04 UTC |
Kovelman HarryChief Medical Officer
|
SaleCommon Stock | 6,700 | $3.76 | $25,182.62 |
DisclosureSEC source: 0000950170-24-104735 · ownership.xml · nonDerivative · entry 1 Kovelman Harry · CIK 0001853204 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 123,556 F1 · price: Represents volume weighted average sales price. Shares were sold in multiple lots, at prices ranging from $3.74 to $3.83 per share, in open market transactions. Reporting Party agrees to provide details of the individual transactions to the SEC upon request. Read SEC document |
| September 04, 2024 Filed Sep 5, 2024 12:27 UTC |
Kovelman HarryChief Medical Officer
|
Tax withholdingCommon Stock | 139 | $3.89 | $540.71 |
DisclosureSEC source: 0000950170-24-103753 · ownership.xml · nonDerivative · entry 2 Kovelman Harry · CIK 0001853204 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 130,256 F2 · shares: Shares were sold on September 4, 2024 solely to cover income taxes on the vesting of restricted stock units on September 2, 2024, pursuant to an irrevocable election made by the Reporting Party in November 2020. Read SEC document |
| September 03, 2024 Filed Sep 5, 2024 12:27 UTC |
Kovelman HarryChief Medical Officer
|
SaleCommon Stock | 2,029 | $4.01 | $8,140.35 |
DisclosureSEC source: 0000950170-24-103753 · ownership.xml · nonDerivative · entry 1 Kovelman Harry · CIK 0001853204 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 130,395 F1 · price: Represents volume weighted average sales price. Shares were sold in multiple lots, at prices ranging from $4.00 to $4.03 per share, in open market transactions. Reporting Party agrees to provide details of the individual transactions to the SEC upon request. Read SEC document |
| August 05, 2024 Filed Aug 8, 2024 01:50 UTC |
Kovelman HarryChief Medical Officer
|
Tax withholdingCommon Stock | 128 | $3.96 | $506.88 |
DisclosureSEC source: 0000950170-24-093230 · ownership.xml · nonDerivative · entry 1 Kovelman Harry · CIK 0001853204 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 132,424 F1 · shares: Shares sold on August 5, 2024 solely to pay income taxes resulting from the vesting a restricted stock unit grant on August 2, 2024, pursuant to an irrevocable election made by the Reporting Party in conjunction with the original grant in November 2020. Read SEC document |
| July 03, 2024 Filed Jul 8, 2024 20:44 UTC |
Kovelman HarryChief Medical Officer
|
Tax withholdingCommon Stock | 121 | $2.85 | $344.85 |
DisclosureSEC source: 0000950170-24-082149 · ownership.xml · nonDerivative · entry 1 Kovelman Harry · CIK 0001853204 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 132,552 F1 · shares: Shares sold on July 3, 2024 solely to pay income taxes resulting from the vesting a restricted stock unit grant on July 2, 2024, pursuant to an irrevocable election made by the Reporting Party in conjunction with the original grant in November 2020. Read SEC document |
| July 01, 2024 Filed Jul 3, 2024 00:09 UTC |
Kovelman HarryChief Medical Officer
|
Tax withholdingCommon Stock | 12,868 | $3.02 | $38,861.36 |
DisclosureSEC source: 0000950170-24-080990 · ownership.xml · nonDerivative · entry 1 Kovelman Harry · CIK 0001853204 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 132,673 F1 · shares: Shares sold solely to pay income taxes resulting from the vesting a restricted stock unit grant on June 28, 2024, pursuant to an irrevocable election made by the Reporting Party on May 12, 2024. Read SEC document |
| July 01, 2024 Filed Jul 3, 2024 00:18 UTC |
Mitchell MicahChief Commercial Officer
|
Tax withholdingCommon Stock | 15,500 | $3.02 | $46,810.00 |
DisclosureSEC source: 0000950170-24-080993 · ownership.xml · nonDerivative · entry 1 Mitchell Micah · CIK 0001746072 · Chief Commercial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 184,098 F1 · shares: Shares sold solely to pay income taxes resulting from the vesting of a restricted stock unit grant on June 28, 2024, pursuant to an irrevocable election made by the Reporting Party on May 10, 2024. Read SEC document |
| July 01, 2024 Filed Jul 3, 2024 00:00 UTC |
HENRY DAVID AChief Financial Officer
|
Tax withholdingCommon Stock | 25,436 | $3.02 | $76,816.72 |
DisclosureSEC source: 0000950170-24-080988 · ownership.xml · nonDerivative · entry 1 HENRY DAVID A · CIK 0001195842 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 378,363 F1 · shares: Shares sold solely to pay income taxes resulting from the vesting of a restricted stock unit grant on June 28, 2024, pursuant to an irrevocable election made by the Reporting Party on May 10, 2024. Read SEC document |
| June 10, 2024 Filed Jun 12, 2024 20:12 UTC |
Kovelman HarryChief Medical Officer
|
Tax withholdingCommon Stock | 5,347 | $3.38 | $18,067.51 |
DisclosureSEC source: 0000950170-24-072450 · ownership.xml · nonDerivative · entry 1 Kovelman Harry · CIK 0001853204 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 145,541 F1 · shares: Shares sold solely to pay income taxes resulting from the vesting of multiple restricted stock unit grants on June 8 and June 9, 2024, pursuant to an irrevocable election made by the Reporting Party on May 12, 2024. F2 · price: Represents the average selling price. Shares were sold in multiple lots at prices ranging from $3.33 to $3.39 per share. The Reporting Party agrees to provide detials of the transactions to the SEC upon request. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.